MercoPress, en Español
Montevideo, December 23rd 2024 - 03:45 UTC
Cancer scientists in Britain are launching what they call the world's first Darwinian drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients.
Get our news on your inbox! Suscribe